Binningen, Switzerland

Petar Polc


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Petar Polc

Introduction

Petar Polc is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of imidazodiazepine derivatives. With a total of 10 patents to his name, his work has had a profound impact on medical science.

Latest Patents

One of Petar Polc's latest patents involves a process for preparing imidazodiazepines. This patent details the synthesis of imidazodiazepine derivatives that have utility in antagonizing the central-depressant properties of 1,4-benzodiazepines. These compounds can serve as antidotes in cases of intoxication and can also be used to shorten anesthesia induced by such substances. The patent outlines various chemical structures and their potential applications in treating conditions related to excessive benzodiazepine intake.

Career Highlights

Throughout his career, Petar Polc has been associated with Hoffmann-La Roche Inc., a leading pharmaceutical company. His work has focused on the development of innovative compounds that address critical medical needs. His expertise in medicinal chemistry has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Petar Polc has collaborated with notable colleagues such as Max Gerecke and Willy Haefely. These partnerships have fostered a collaborative environment that has led to advancements in pharmaceutical research and development.

Conclusion

Petar Polc's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new medical treatments and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…